BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 35874679)

  • 1. Added Value of Reanalysis of Whole Exome- and Whole Genome Sequencing Data From Patients Suspected of Primary Immune Deficiency Using an Extended Gene Panel and Structural Variation Calling.
    Mørup SB; Nazaryan-Petersen L; Gabrielaite M; Reekie J; Marquart HV; Hartling HJ; Marvig RL; Katzenstein TL; Masmas TN; Lundgren J; Murray DD; Helleberg M; Borgwardt L
    Front Immunol; 2022; 13():906328. PubMed ID: 35874679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reanalysis of whole-exome sequencing (WES) data of children with neurodevelopmental disorders in a standard patient care context.
    van Slobbe M; van Haeringen A; Vissers LELM; Bijlsma EK; Rutten JW; Suerink M; Nibbeling EAR; Ruivenkamp CAL; Koene S
    Eur J Pediatr; 2024 Jan; 183(1):345-355. PubMed ID: 37889289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanding the Clinical and Genetic Spectra of Primary Immunodeficiency-Related Disorders With Clinical Exome Sequencing: Expected and Unexpected Findings.
    Rudilla F; Franco-Jarava C; Martínez-Gallo M; Garcia-Prat M; Martín-Nalda A; Rivière J; Aguiló-Cucurull A; Mongay L; Vidal F; Solanich X; Irastorza I; Santos-Pérez JL; Tercedor Sánchez J; Cuscó I; Serra C; Baz-Redón N; Fernández-Cancio M; Carreras C; Vagace JM; Garcia-Patos V; Pujol-Borrell R; Soler-Palacín P; Colobran R
    Front Immunol; 2019; 10():2325. PubMed ID: 31681265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-genome sequencing offers additional but limited clinical utility compared with reanalysis of whole-exome sequencing.
    Alfares A; Aloraini T; Subaie LA; Alissa A; Qudsi AA; Alahmad A; Mutairi FA; Alswaid A; Alothaim A; Eyaid W; Albalwi M; Alturki S; Alfadhel M
    Genet Med; 2018 Nov; 20(11):1328-1333. PubMed ID: 29565419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase in diagnostic yield achieved for 174 whole-exome sequencing cases reanalyzed 1-2 years after initial analysis.
    Liu Y; Teng Y; Li Z; Cui J; Liang D; Wu L
    Clin Chim Acta; 2021 Dec; 523():163-168. PubMed ID: 34560057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants.
    Belkadi A; Bolze A; Itan Y; Cobat A; Vincent QB; Antipenko A; Shang L; Boisson B; Casanova JL; Abel L
    Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5473-8. PubMed ID: 25827230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid Low-Cost Microarray-Based Genotyping for Genetic Screening in Primary Immunodeficiency.
    Suratannon N; van Wijck RTA; Broer L; Xue L; van Meurs JBJ; Barendregt BH; van der Burg M; Dik WA; Chatchatee P; Langerak AW; Swagemakers SMA; Goos JAC; Mathijssen IMJ; Dalm VASH; Suphapeetiporn K; Heezen KC; Drabwell J; Uitterlinden AG; van der Spek PJ; van Hagen PM;
    Front Immunol; 2020; 11():614. PubMed ID: 32373116
    [No Abstract]   [Full Text] [Related]  

  • 8. Whole exome and genome sequencing in mendelian disorders: a diagnostic and health economic analysis.
    Ewans LJ; Minoche AE; Schofield D; Shrestha R; Puttick C; Zhu Y; Drew A; Gayevskiy V; Elakis G; Walsh C; Adès LC; Colley A; Ellaway C; Evans CA; Freckmann ML; Goodwin L; Hackett A; Kamien B; Kirk EP; Lipke M; Mowat D; Palmer E; Rajagopalan S; Ronan A; Sachdev R; Stevenson W; Turner A; Wilson M; Worgan L; Morel-Kopp MC; Field M; Buckley MF; Cowley MJ; Dinger ME; Roscioli T
    Eur J Hum Genet; 2022 Oct; 30(10):1121-1131. PubMed ID: 35970915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-exome Sequencing for the Identification of Rare Variants in Primary Immunodeficiency Genes in Children With Sepsis: A Prospective, Population-based Cohort Study.
    Borghesi A; Trück J; Asgari S; Sancho-Shimizu V; Agyeman PKA; Bellos E; Giannoni E; Stocker M; Posfay-Barbe KM; Heininger U; Bernhard-Stirnemann S; Niederer-Loher A; Kahlert CR; Natalucci G; Relly C; Riedel T; Kuehni CE; Thorball CW; Chaturvedi N; Martinon-Torres F; Kuijpers TW; Coin L; Wright V; Herberg J; Levin M; Aebi C; Berger C; Fellay J; Schlapbach LJ
    Clin Infect Dis; 2020 Dec; 71(10):e614-e623. PubMed ID: 32185379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and economics of targeted panel versus whole-exome sequencing in 878 patients with suspected primary immunodeficiency.
    Platt CD; Zaman F; Bainter W; Stafstrom K; Almutairi A; Reigle M; Weeks S; Geha RS; Chou J;
    J Allergy Clin Immunol; 2021 Feb; 147(2):723-726. PubMed ID: 32888943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From cytogenetics to cytogenomics: whole-genome sequencing as a first-line test comprehensively captures the diverse spectrum of disease-causing genetic variation underlying intellectual disability.
    Lindstrand A; Eisfeldt J; Pettersson M; Carvalho CMB; Kvarnung M; Grigelioniene G; Anderlid BM; Bjerin O; Gustavsson P; Hammarsjö A; Georgii-Hemming P; Iwarsson E; Johansson-Soller M; Lagerstedt-Robinson K; Lieden A; Magnusson M; Martin M; Malmgren H; Nordenskjöld M; Norling A; Sahlin E; Stranneheim H; Tham E; Wincent J; Ygberg S; Wedell A; Wirta V; Nordgren A; Lundin J; Nilsson D
    Genome Med; 2019 Nov; 11(1):68. PubMed ID: 31694722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Comparison of Whole Genome Sequencing to Multigene Panel Testing in Hypertrophic Cardiomyopathy Patients.
    Cirino AL; Lakdawala NK; McDonough B; Conner L; Adler D; Weinfeld M; O'Gara P; Rehm HL; Machini K; Lebo M; Blout C; Green RC; MacRae CA; Seidman CE; Ho CY;
    Circ Cardiovasc Genet; 2017 Oct; 10(5):. PubMed ID: 29030401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Yield of Next Generation Sequencing in Genetically Undiagnosed Patients with Primary Immunodeficiencies: a Systematic Review.
    Yska HAF; Elsink K; Kuijpers TW; Frederix GWJ; van Gijn ME; van Montfrans JM
    J Clin Immunol; 2019 Aug; 39(6):577-591. PubMed ID: 31250335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced resource utilization with early use of next-generation sequencing in rare genetic diseases in an Asian cohort.
    Nazeha N; Koh AL; Kam S; Lim JY; Goh DLM; Jamuar SS; Graves N
    Am J Med Genet A; 2022 Dec; 188(12):3482-3491. PubMed ID: 36156406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validated WGS and WES protocols proved saliva-derived gDNA as an equivalent to blood-derived gDNA for clinical and population genomic analyses.
    Kvapilova K; Misenko P; Radvanszky J; Brzon O; Budis J; Gazdarica J; Pos O; Korabecna M; Kasny M; Szemes T; Kvapil P; Paces J; Kozmik Z
    BMC Genomics; 2024 Feb; 25(1):187. PubMed ID: 38365587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary Immunodeficiencies in India: Molecular Diagnosis and the Role of Next-Generation Sequencing.
    Arunachalam AK; Maddali M; Aboobacker FN; Korula A; George B; Mathews V; Edison ES
    J Clin Immunol; 2021 Feb; 41(2):393-413. PubMed ID: 33225392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of Whole-Exome Sequencing for the Identification of Causal Mutations in Patients with Suspected Inherited Ocular Diseases.
    Ordoñez-Labastida V; Montes-Almanza L; García-Martínez F; Zenteno JC
    Rev Invest Clin; 2022; 74(4):219-226. PubMed ID: 36087940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic diagnoses in epilepsy: The impact of dynamic exome analysis in a pediatric cohort.
    Rochtus A; Olson HE; Smith L; Keith LG; El Achkar C; Taylor A; Mahida S; Park M; Kelly M; Shain C; Rockowitz S; Rosen Sheidley B; Poduri A
    Epilepsia; 2020 Feb; 61(2):249-258. PubMed ID: 31957018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of New Copy Number Variation and the Evaluation of a CNV Detection Tool for NGS Panel Data in Polish Familial Hypercholesterolemia Patients.
    Rutkowska L; Pinkier I; Sałacińska K; Kępczyński Ł; Salachna D; Lewek J; Banach M; Matusik P; Starostecka E; Lewiński A; Płoski R; Stawiński P; Gach A
    Genes (Basel); 2022 Aug; 13(8):. PubMed ID: 36011335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 2020 update on the use of genetic testing for patients with primary immunodeficiency.
    Chinn IK; Orange JS
    Expert Rev Clin Immunol; 2020 Sep; 16(9):897-909. PubMed ID: 32822560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.